Alexion Pharma (ALXN) Misses Q1 EPS by 4c

April 23, 2015 6:32 AM EDT

Alexion Pharma (NASDAQ: ALXN) reported Q1 EPS of $1.28, $0.04 worse than the analyst estimate of $1.32. Revenue for the quarter came in at $600.3 million versus the consensus estimate of $594.4 million.

For earnings history and earnings-related data on Alexion Pharma (ALXN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings